Xiao Ji-Nan, Yan Ting-Hua, Yu Rui-Ming, Gao Yi, Zeng Wen-Long, Lu Sui-Wan, Que Hua-Xing, Liu Ze-Ping, Jiang Jin-Hua
Department of Radiotherapy, Second Hospital of Longyan City, Longyan, 364000, Fujian, China.
Department of Oncology and Internal Medicine, Humanity Hospital of Longyan City, Longyan, 364000, Fujian, China.
J Cancer Res Clin Oncol. 2017 Jun;143(6):981-990. doi: 10.1007/s00432-017-2370-1. Epub 2017 Mar 8.
Long non-coding RNA (LncRNA) urothelial carcinoma-associated 1 (UCA1) is reported to be dysregulated in hepatocellular carcinoma (HCC) progression. However, the functions of UCA1 in HCC still need further study. The aim is to detect the role of UCA1 involving in HCC cells proliferation and invasion, and epithelial-mesenchymal transition (EMT).
The quantitative real-time PCR was used to detect the UCA1 and miR-203 expression levels in 60 cases' HCC tissues and adjacent normal tissues. Western blotting analysis was performed to detect the EMT markers E-cadherin, Vimentin and transcription factor Snail1, Snail2 expression. Luciferase reporter assay, RNA immunoprecipitation (RIP) and pull-down assays were used to evaluate whether miR-203 was a target of UCA1.
Our results showed that UCA1 was markedly upregulated in HCC tissues and higher UCA1 expression in HCC was positively associated with tumor size, vascular invasion and American Joint Committee on Cancer (AJCC) stage (P < 0.05). Furthermore, gain-of-function and loss-of-function analysis showed that UCA1 knockdown inhibited HCC cells proliferation and invasion in vitro and xenograft tumour growth in vivo. Moreover, UCA1 overexpression promoted cell epithelial-mesenchymal transition (EMT) in HCC via effectively sponging to miR-203 and thereby activating the expression of transcription factor Snail2.
Our results identified that UCA1/miR-203/Snail2 pathway might involve in HCC progression. Inhibition of UCA1 acted as a promising therapeutic target for HCC patients.
据报道,长链非编码RNA(LncRNA)尿路上皮癌相关1(UCA1)在肝细胞癌(HCC)进展过程中表达失调。然而,UCA1在HCC中的功能仍需进一步研究。本研究旨在检测UCA1在HCC细胞增殖、侵袭及上皮-间质转化(EMT)中的作用。
采用定量实时PCR检测60例HCC组织及癌旁正常组织中UCA1和miR-203的表达水平。通过蛋白质免疫印迹分析检测EMT标志物E-钙黏蛋白、波形蛋白以及转录因子Snail1、Snail2的表达。采用荧光素酶报告基因检测、RNA免疫沉淀(RIP)及下拉实验评估miR-203是否为UCA1的靶标。
我们的研究结果显示,UCA1在HCC组织中显著上调,且HCC中较高的UCA1表达与肿瘤大小、血管侵犯及美国癌症联合委员会(AJCC)分期呈正相关(P < 0.05)。此外,功能获得和功能缺失分析表明,敲低UCA1可抑制体外HCC细胞的增殖和侵袭以及体内异种移植瘤的生长。而且,UCA1过表达通过有效吸附miR-203从而激活转录因子Snail2的表达,促进HCC中的细胞上皮-间质转化(EMT)。
我们的研究结果表明,UCA1/miR-203/Snail2通路可能参与HCC的进展。抑制UCA1有望成为HCC患者的治疗靶点。